AtaiBeckley (ATAI) Asset Utilization Ratio (2021 - 2025)

AtaiBeckley (ATAI) reported Asset Utilization Ratio of 0.02 for Q1 2025, up 2247.06% on a YoY basis from 0.0 in Q1 2024, and up 1382.4% sequentially from 0.0 in Q2 2024.

AtaiBeckley (ATAI) Asset Utilization Ratio (2021 - 2025) Analysis & Trends

AtaiBeckley (ATAI) has 5 years of Asset Utilization Ratio data on file, last reported at 0.02 in Q1 2025.

  • For the quarter ending Q1 2025, Asset Utilization Ratio rose 2247.06% year-over-year to 0.02; the trailing twelve-month figure through Mar 2025 stood at 0.02 (up 2247.06% YoY), and the FY2024 full-year result was 0.0, up 29.72% from the prior year.
  • Asset Utilization Ratio advanced to 0.02 in Q1 2025, from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 22.76 in Q3 2021 to a low of 0.0 in Q4 2022.
  • A 5-year average of 4.62 and a median of 0.0 in 2023 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio slumped 99.99% in 2022 and surged 2247.06% in 2025, its largest moves.
  • Tracing ATAI's Asset Utilization Ratio over 5 years: stood at 7.22 in 2021, then tumbled by 99.99% to 0.0 in 2022, then jumped by 45.77% to 0.0 in 2023, then jumped by 49.38% to 0.0 in 2024, then jumped by 1382.4% to 0.02 in 2025.
  • Business Quant data shows ATAI's Asset Utilization Ratio at 0.02 in Q1 2025, 0.0 in Q2 2024, and 0.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 AtaiBeckley 2.56 Bn 2.56 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 0.02
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Dec 31, 2021 7.22
Sep 30, 2021 22.76
Jun 30, 2021 22.46
Mar 31, 2021 3.01